IRVINE, Calif., July 7, 2015 /PRNewswire/ — Interventional Spine®, Inc. a healthcare manufacturer of Minimally Invasive Spine products announced today that it has expanded its management team with the appointment of Joseph Darling as Vice President and Chief Operating Officer.
Mr. Darling joins Interventional Spine following a distinguished career exceeding 25 years in both the pharmaceutical and medical device sectors. During his tenure, Darling has held various senior management positions with public traded global companies including Smith and Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter International, and Abbott Laboratories. Most recently, Mr. Darling served as President of Linvatec Corporation and Executive Vice President, Commercial Operations at CONMED Corporation where he led the global development and launch of multiple new products, strategic planning, and the acquisition of innovative new technologies.
“Joe brings a wealth of experience and solid credentials to Interventional Spine’s management team. His leadership and strategic focus that spans his career will be a great addition to our management team. We intend to call upon his years of experience, and to capitalize on his strengths in strategic planning, market development, and his global knowledge to expand our efforts world wide. His proven ability to build teams will benefit our organization as we continue to grow,” said Walter A. Cuevas, Chief Executive Officer.
“I am very pleased to take on this expanded role with Interventional Spine as we continue to develop our strategy in the spine market, I look forward to working closely with Walter and the management team to expand our presence and strength in this important market,” said Mr. Darling.
Interventional Spine®, Inc. is a privately held company based in Irvine, California, that designs, develops and markets patented minimally invasive implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company’s unique product introduction systems, Interventional Spine’s products provide benefits to patients, surgeons and hospitals alike. More information on the Company and its products can be found at: www.i-spineinc.com
FOR FURTHER INFORMATION CONTACT:
Walter A. Cuevas
949-472-0006
SOURCE Interventional Spine, Inc.
RELATED LINKS
http://www.i-spineinc.com